Aquablation: a novel and minimally invasive surgery for benign prostate enlargement
- PMID: 29899759
- PMCID: PMC5993070
- DOI: 10.1177/1756287218760518
Aquablation: a novel and minimally invasive surgery for benign prostate enlargement
Abstract
Aquablation is a minimally invasive surgical technology for benign prostate enlargement, which uses high-pressure saline to remove parenchymal tissue through a heat-free mechanism of hydrodissection. Early results show this to be a promising surgical strategy with a strong morbidity profile and reduced resection time. This review serves to provide an overview of the technique and evaluate its safety and efficacy.
Keywords: aquablation; benign prostatic hyperplasia; minimally invasive surgery.
Conflict of interest statement
Conflict of interest statement: The authors declare no conflicts of interest in preparing this article.
References
-
- Rosario DJ, Bryant R. Benign prostatic hyperplasia. Surgery (Oxford) 2002; 20: 268–272.
-
- de la Rosette JJMCH. What we do and don’t know about benign prostatic hyperplasia. Curr Opin Urol 2000; 10: 1–2.
-
- Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol 2005; 173: 1309–1313. - PubMed
-
- Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 2006; 50: 969–980. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources